NRXS
NeurAxis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.96
−1.81%Aug 19, 2026, 00:00 UTC
Neuraxis, Inc. granted restricted stock units to executives Brian Carrico, Adrian Miranda, and Thomas Carrico on July 24, 2026, as part of their compensation packages.
Aug 11, 2026, 18:47 UTC
NeurAxis, Inc. held its Q2 2026 earnings call on August 11, 2026.
Source: